Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 420

    1.

    Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review.

    Hull RD, Pineo GF, Stein PD, Mah AF, MacIsaac SM, Dahl OE, Butcher M, Brant RF, Ghali WA, Bergqvist D, Raskob GE.

    Ann Intern Med. 2001 Nov 20;135(10):858-69. Review.PMID: 11712876 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review.

    Hull RD, Pineo GF, Stein PD, Mah AF, MacIsaac SM, Dahl OE, Ghali WA, Butcher MS, Brant RF, Bergqvist D, Hamulyák K, Francis CW, Marder VJ, Raskob GE.

    Arch Intern Med. 2001 Sep 10;161(16):1952-60. Review.PMID: 11525697 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials.

    Gould MK, Dembitzer AD, Doyle RL, Hastie TJ, Garber AM.

    Ann Intern Med. 1999 May 18;130(10):800-9.PMID: 10366369 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials.

    Eikelboom JW, Quinlan DJ, Douketis JD.

    Lancet. 2001 Jul 7;358(9275):9-15.PMID: 11454370 [PubMed - indexed for MEDLINE]Related articles

    5.

    A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty.

    Freedman KB, Brookenthal KR, Fitzgerald RH Jr, Williams S, Lonner JH.

    J Bone Joint Surg Am. 2000 Jul;82-A(7):929-38.PMID: 10901307 [PubMed - indexed for MEDLINE]Related articles

    6.

    Ardeparin sodium for extended out-of-hospital prophylaxis against venous thromboembolism after total hip or knee replacement. A randomized, double-blind, placebo-controlled trial.

    Heit JA, Elliott CG, Trowbridge AA, Morrey BF, Gent M, Hirsh J.

    Ann Intern Med. 2000 Jun 6;132(11):853-61.PMID: 10836911 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison. North American Fragmin Trial Investigators.

    Hull RD, Pineo GF, Francis C, Bergqvist D, Fellenius C, Soderberg K, Holmqvist A, Mant M, Dear R, Baylis B, Mah A, Brant R.

    Arch Intern Med. 2000 Jul 24;160(14):2208-15.PMID: 10904465 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.

    Chande N, McDonald JW, Macdonald JK.

    Cochrane Database Syst Rev. 2008 Apr 16;(2):CD006774. Review.PMID: 18425969 [PubMed - indexed for MEDLINE]Related articles

    9.

    Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.

    Kanaan AO, Silva MA, Donovan JL, Roy T, Al-Homsi AS.

    Clin Ther. 2007 Nov;29(11):2395-405. Review.PMID: 18158080 [PubMed - indexed for MEDLINE]Related articles

    10.

    Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.

    Whang PG, Lieberman JR.

    Am J Orthop. 2002 Sep;31(9 Suppl):31-6. Review.PMID: 12349893 [PubMed - indexed for MEDLINE]Related articles

    11.

    Extended venous thromboembolism prophylaxis after total hip replacement: a comparison of low-molecular-weight heparin with oral anticoagulant.

    Samama CM, Vray M, Barré J, Fiessinger JN, Rosencher N, Lecompte T, Potron G, Basile J, Hull R, Desmichels D; SACRE Study Investigators.

    Arch Intern Med. 2002 Oct 28;162(19):2191-6.PMID: 12390061 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Summaries for patients. Low-molecular-weight heparin given for several weeks after hip surgery prevents deep venous thrombosis.

    [No authors listed]

    Ann Intern Med. 2001 Nov 20;135(10):S-55. Review. No abstract available. PMID: 11757493 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes.

    Douketis JD, Eikelboom JW, Quinlan DJ, Willan AR, Crowther MA.

    Arch Intern Med. 2002 Jul 8;162(13):1465-71.PMID: 12090882 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Efficacy and cost of low-molecular-weight heparin compared with standard heparin for the prevention of deep vein thrombosis after total hip arthroplasty.

    Anderson DR, O'Brien BJ, Levine MN, Roberts R, Wells PS, Hirsh J.

    Ann Intern Med. 1993 Dec 1;119(11):1105-12.PMID: 8239230 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery?

    Strebel N, Prins M, Agnelli G, Büller HR.

    Arch Intern Med. 2002 Jul 8;162(13):1451-6. Review.PMID: 12090880 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial.

    Camporese G, Bernardi E, Prandoni P, Noventa F, Verlato F, Simioni P, Ntita K, Salmistraro G, Frangos C, Rossi F, Cordova R, Franz F, Zucchetta P, Kontothanassis D, Andreozzi GM; KANT (Knee Arthroscopy Nadroparin Thromboprophylaxis) Study Group.

    Ann Intern Med. 2008 Jul 15;149(2):73-82.PMID: 18626046 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients.

    Dentali F, Douketis JD, Gianni M, Lim W, Crowther MA.

    Ann Intern Med. 2007 Feb 20;146(4):278-88.PMID: 17310052 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.
    20.

    Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.

    van Der Heijden JF, Hutten BA, Büller HR, Prins MH.

    Cochrane Database Syst Rev. 2000;(4):CD002001. Review. Update in: Cochrane Database Syst Rev. 2002;(1):CD002001. PMID: 11034739 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data